dc.contributor.author | Salehi, R | |
dc.contributor.author | Rasouli, S | |
dc.contributor.author | Hamishehkar, H | |
dc.date.accessioned | 2018-08-26T07:42:51Z | |
dc.date.available | 2018-08-26T07:42:51Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/47892 | |
dc.description.abstract | Two novel dual temperature/pH-sensitive superparamagnetic nanogels were developed with the aim of simultaneously delivering two different anticancer drugs, doxorubicin (DOX) and methotrexate (MTX). The studied copolymers were characterized by H-1 NMR, SEM, and FTIR spectroscopy. Morphological investigations showed that both blank and drug-loaded nanogels had uniform shapes with a mean diameter of less than 30 nm. The drug storage/release behaviors were investigated. The nanogels showed an encapsulation efficiency of about 95% for both drugs. The cumulative in vitro release of the DOX/MTX-loaded nanogels exhibited an apparent thermo/pH-triggered controlled drug release in a sustained manner that was able to distinguish between tumor tissues. The cytotoxicity assay of a blank carrier to MCF7 and MDA-MB-231 cell lines indicated that the nanogels were suitable as drug carriers. Cell viability experiments further confirmed that the co-administration of DOX with MTX had a superior cytotoxicity to the mentioned cells compared with free dual drug-or single drug-loaded forms. Therefore, dual anticancer drug-loaded thermo/pH-sensitive nanogels have the potential to be used for cancer therapy, because they maintain a low premature drug release during blood circulation while having a rapid release upon reaching tumorous tissue. (C) 2015 Elsevier B.V. All rights reserved. | |
dc.language.iso | English | |
dc.relation.ispartof | INTERNATIONAL JOURNAL OF PHARMACEUTICS | |
dc.subject | Cancer | |
dc.subject | Dual drug delivery | |
dc.subject | Magnetic nanogels | |
dc.subject | Stimuli-responsive | |
dc.subject | Targeted delivery | |
dc.title | Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate | |
dc.type | Article | |
dc.citation.volume | 487 | |
dc.citation.issue | 1-2 | |
dc.citation.spage | 274 | |
dc.citation.epage | 284 | |
dc.citation.index | Web of science | |
dc.identifier.DOI | https://doi.org/10.1016/j.ijpharm.2015.04.051 | |